Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 182.05 2.36
Ong Corp 426.85 0.20
Tata Pow 93.55 0.27
Tata Stl 537.60 0.19
Axis Ban 402.35 0.92
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:524500NSE:KILITCHBloomberg:KILD@INReuters:KIDI.BO
Market Lot: 1Face Value: 10ISIN Demat: INE729D01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
11-FEB-10 Kilitch Drugs manufactures Parenteral Formulations, it lost total of 29.92% during last 5 weeks. Its share price as on Feb. 10, 2010 stood at Rs 98. 31-DEC-09 Kilitch Drugs India today announced that it has incorporated a subsidiary company under the name and style of Eyecare Kilitch to focus on ophthalmology related products. 23-NOV-09 With reference to the reports appearing in the Press in Sri Lanka on Nov. 20, 2009, Kilitch Drugs...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Kilitch Drugs (India) standalone quarterly profit soars 2.30 times   -IRIS 18-Nov-13
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2014(12)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 142.16319.901068.21
Other Income62.9291.5110.94
Total Income205.08411.411079.15
Cost of goods sold186.87368.53974.66
OPBDIT18.2142.88104.49
PAT11.7732.83886.23
Gross Block---
Equity capital132.32132.32132.32
EPS (Rs.)-2.4766.98
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-7.89 - 36.620.61 - 1.32
Debt / Equity (x)---
Operating margin (% of OI) 8.910.4 9.7
Net margin (% of OI) 5.7 8.082.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
C - 301/ 2, MIDC
TTC Industrial Area
Pawane Village
Thane
Maharashtra-400 705
PHONE
(022) 2767 0322/ 2768 0913/ 6514 4185
FAX
(022) 2768 0912
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer